CBUS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

CB

Volume

45.20K

Next Earnings

November 12th

Loading chart

CB

CBUSCibus, Inc. Class A Common Stock

CBUS

Pay with—

Available Balance0.00

CB

Mkt Cap

$98.6M

Volume

45.20K

Next Earnings

November 12th

Chart Financials Earnings News About Insider Filings

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value CreationCibus, Inc. (Nasdaq: CBUS) announced the appointment of Craig Wichner, founder of Farmland LP, as Chief Executive Officer, with Peter Beetham transitioning to President and Chief Operating Officer. The leadership change is part of the company's succession planning strategy as it focuses on commercializing its gene-editing technology for plant traits. Wichner brings experience in farmland investment management and regenerative agriculture practices.GlobeNewswire Inc. · Jun 8, 2026

Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and ProductionCibus, Inc. has successfully transferred gene-edited herbicide tolerance traits in rice to its partner Interoc, marking a strategic milestone toward commercializing enhanced seed products in the Latin American market. The achievement demonstrates Cibus' ability to deliver traits on schedule using its Rapid Trait Development System, with expectations for additional gene-edited materials to be delivered to partners in the coming year as regulatory frameworks for gene editing continue to harmonize globally.GlobeNewswire Inc. · May 4, 2026

Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding InitiativeCibus, Inc. has been selected as a key technology partner in a UK Government-funded research project to develop oilseed rape varieties with resistance to Light Leaf Spot disease, which has caused estimated yield losses of £300 million. The LLS-ERASED project will utilize Cibus' proprietary Rapid Trait Development System to create durable, multi-disease resistant varieties, involving 12 industry and academic partners including the John Innes Centre and University of Hertfordshire.GlobeNewswire Inc. · Feb 6, 2026

What's Driving Cibus Inc.'s Pre-Market Surge Amid Trump's China Trade Warning?Cibus Inc. experienced a pre-market surge of 23.81% following President Trump's trade comments about China, specifically regarding soybeans and cooking oil trade tensions.Benzinga · Oct 15, 2025

Cibus, Inc. Announces Closing of $27.5 Million Public OfferingCibus, Inc., a leading agricultural biotechnology company, announced the closing of a $27.5 million public offering to fund further development of its weed management productivity traits in Rice and for working capital and general corporate purposes.GlobeNewswire Inc. · Jun 10, 2025

Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside ChatCibus, a leading agricultural biotechnology company, announced that its Co-Founder, President, and Interim CEO participated in the BofA Securities 2025 AgTech Virtual Conference. The company discussed its gene editing platform, productivity trait pipeline, and recent regulatory developments supporting agricultural innovation.GlobeNewswire Inc. · May 27, 2025

Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference CallCibus, a leading agricultural biotechnology company, will report its first quarter 2025 financial results on May 8, 2025 and host a conference call to discuss the results and provide company updates.GlobeNewswire Inc. · Apr 25, 2025

Cibus Announces Important Update to Rice Gene Editing Conversion RatesCibus, a leading agricultural technology company, has issued a correction regarding the rice conversion rates previously disclosed in its January 16, 2025 press release. The company has concluded that the gene editing conversion rates of 10-25% in Rice have not been reconfirmed based on subsequent experiments and high variability in the conversion rate data.GlobeNewswire Inc. · Feb 14, 2025

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial OfficerTotus Medicines, a company developing small molecule medicines using DNA-encoded covalent library technology and AI/ML, has appointed Simon Harnest as its new Chief Financial Officer. This appointment comes as the company prepares to advance its lead covalent PI3Kα inhibitor, TOS-358, following positive Phase 1 results.GlobeNewswire Inc. · Jan 28, 2025

Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in CanolaCibus, an agricultural technology company, announced that its next-generation herbicide tolerance (HT2) trait in canola has shown increased tolerance to a novel herbicide in greenhouse testing. This milestone paves the way for larger-scale field testing in 2025, as Cibus aims to provide farmers with additional weed control options.GlobeNewswire Inc. · Nov 5, 2024

to start trading

CB

CBUSCibus, Inc. Class A Common Stock

CBUS

Pay with—

Available Balance0.00

Your PositionYou don't own any CBUS yet.

Related Tickers

Earnings